VanEck Pharmaceutical ETF (PPH) is a healthcare and biotech ETF. As of October 9, 2026, ETF Copilot scores PPH 5.7 out of 10 — highest on Quality (8.3), lowest on Value (2.4). It trades at 26.6 times earnings, against its own median of 22.4. Its ten largest holdings are 72% of the fund.
What stands out in PPH's data
Global large-cap pharmaceutical firms, weighted by market size.
Earns more on its capital than the typical health-care fund — a sign of pricing power in branded drugs.
Return on invested capital of 23.6% sits above the category median of 18.9% and its own 19.6% historical median. Top holdings concentration runs at 71.5%.
A focused position on the world's largest drug companies, for a portfolio that wants stable health-care exposure.
Why did PPH move this week? It rose 2.2% in the week to October 9, 2026 — Eli Lilly and Haleon drove it
PPH rose 2.2% in the week to October 9, 2026. The holdings that moved it most were Eli Lilly (+3.2%), Haleon (+5.9%) and Cencora (+4.8%); Bristol-Myers Squibb (−3.3%) pushed the other way.
How is PPH rated? ETF Copilot scores VanEck Pharmaceutical ETF (PPH) 5.7 out of 10
As of October 9, 2026, ETF Copilot scores VanEck Pharmaceutical ETF (PPH) 5.7 out of 10 overall.
ETF Copilot scores (0–10 scale, higher is better):
- Overall: 5.7 / 10
- Growth: 6.5 / 10
- Value: 2.4 / 10
- Risk: 6.9 / 10
- Quality: 8.3 / 10
- Return: 4.3 / 10
Is PPH expensive right now? It trades at 26.6 times earnings, against its own median of 22.4
As of October 9, 2026, PPH is more expensive than 84% of its own last 9 years.
Trailing 12 months, built from PPH's holdings. How we calculate this →
What's inside PPH?
What's inside PPH: Size (Large 95%, Mid 5%, Small 1%); Geography (International 33%, US 67%).
What are PPH's top holdings? The ten largest are 72% of the fund
Eli Lilly, Merck, Novo Nordisk A/S, Pfizer, Teva Pharmaceutical Industries, Bristol-Myers Squibb, McKesson, Amerisourcebergen, GSK and Abbvie are PPH's largest holdings, in that order.
More concentrated than 91% of Health & Biotech ETFs.
Half of PPH's weight sits in its 6 largest positions, and once those weights are taken into account it behaves like 11 equally weighted holdings.
What is PPH's expense ratio? 0.36% a year
As of October 9, 2026, PPH charges 0.36% a year, yields 1.93% and holds $1.0B in assets across 25 positions.
| Measure | PPH |
|---|---|
| Expense ratio | 0.36% |
| Dividend yield | 1.93% |
| Assets under management | $1.0B |
| Holdings | 25 |
Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.
Cite this
ETF Copilot, “VanEck Pharmaceutical ETF (PPH) scores and holdings analysis”, as of October 9, 2026.
https://etf-copilot.com/etf/pph
ETF Copilot Pro unlocks PPH's price and what each holding weighs.
Try Pro free →